Facts Don't Lie: Barington Capital Sends Letter to Matthews International Shareholders Debunking the Company's False Narratives and Reinforcing its Case for Change
enGene to Present Three Posters at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) Highlighting the Ongoing Clinical Development of Detalimogene Voraplasmid for the Treatment of Non-Muscle Inv
Safe Pro Enters Multi-Year Agreement for its Patented Drone AI Demining Platform with Ukraine's Leading Grain Export and Agricultural Organization NIBULON Ltd.